Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Recovery Research Excellence Forum

CARE
Collaborative Advancement of Recovery Excellence
Translating science to service, powered by Gloo

News
06/17/2021

Tom Valentino, Senior Editor

Tom Valentino, Senior Editor
A report by multiple addiction treatment and behavioral health executives has brought into focus the toll that the COVID-19 pandemic has taken both on the mental health of the nation, as well as the treatment industry.
A report by multiple addiction treatment and behavioral health executives has brought into focus the toll that the COVID-19 pandemic has taken both on the mental health of the nation, as well as the treatment industry.
A report by multiple addiction...
06/17/2021
Behavioral Healthcare Executive
News
06/16/2021

Tom Valentino, Senior Editor

Tom Valentino, Senior Editor
A new clinical trial will look to determine whether delivering integrated services at mobile clinics can improve both HIV and substance use outcomes among individuals with opioid use disorder who inject drugs.
A new clinical trial will look to determine whether delivering integrated services at mobile clinics can improve both HIV and substance use outcomes among individuals with opioid use disorder who inject drugs.
A new clinical trial will look...
06/16/2021
Addiction Professional
News
06/08/2021

Tom Valentino, Senior Editor

Tom Valentino, Senior Editor
Shatterproof, the not-for-profit advocacy group focused on addressing the addiction crisis in the United States, announced on Tuesday that it is expanding the availability of a tool it developed to help individuals connect with addiction...
Shatterproof, the not-for-profit advocacy group focused on addressing the addiction crisis in the United States, announced on Tuesday that it is expanding the availability of a tool it developed to help individuals connect with addiction...
Shatterproof, the not-for-profit...
06/08/2021
Behavioral Healthcare Executive
05/11/2021
In a meta-analysis of 157 clinical trials, contingency management programs were found to be the most beneficial treatment modality for cocaine use disorder among adults. Findings, compiled by researchers from Stanford University, Veterans...
In a meta-analysis of 157 clinical trials, contingency management programs were found to be the most beneficial treatment modality for cocaine use disorder among adults. Findings, compiled by researchers from Stanford University, Veterans...
In a meta-analysis of 157...
05/11/2021
Addiction Professional
After 18 Months, CODAC Partnership with Mass. Sheriff’s Department Getting Results
03/19/2021
A collaboration between the Hampden County (Massachusetts) Sheriff’s Department and CODAC Behavioral Healthcare to provide medication-assisted treatment to incarcerated individuals with substance use disorders is making headway 18 months...
A collaboration between the Hampden County (Massachusetts) Sheriff’s Department and CODAC Behavioral Healthcare to provide medication-assisted treatment to incarcerated individuals with substance use disorders is making headway 18 months...
A collaboration between the...
03/19/2021
Addiction Professional
In-Office Provision of Buprenorphine Ups Retention Rates for OUD Patients in Study
02/11/2021
A study conducted by Cordant Health Solutions and Northwest Integrated Health in Tacoma, Washington, found that opioid use disorder patients who had been prescribed buprenorphine demonstrated higher rates of retention and improved health...
A study conducted by Cordant Health Solutions and Northwest Integrated Health in Tacoma, Washington, found that opioid use disorder patients who had been prescribed buprenorphine demonstrated higher rates of retention and improved health...
A study conducted by Cordant...
02/11/2021
Addiction Professional
News
01/28/2021
A partnership with students at the University of Minnesota has resulted in a new way for the Hazelden Betty Ford Foundation to gain a better understanding the factors that put patients at greater risk for relapse.
A partnership with students at the University of Minnesota has resulted in a new way for the Hazelden Betty Ford Foundation to gain a better understanding the factors that put patients at greater risk for relapse.
A partnership with students at...
01/28/2021
Addiction Professional
News
01/14/2021
Findings in a Phase III clinical trial released by NIH showed that a combination of two medications—injectable naltrexone and oral bupropion—were safe and effective in the treatment of adults with moderate or severe methamphetamine use...
Findings in a Phase III clinical trial released by NIH showed that a combination of two medications—injectable naltrexone and oral bupropion—were safe and effective in the treatment of adults with moderate or severe methamphetamine use...
Findings in a Phase III clinical...
01/14/2021
Addiction Professional
News
01/12/2021
Results of a NIDA-supported pilot study released on Monday showed that collaboration between physicians and pharmacists could lead to improved medication adherence among patients being treated for opioid use disorder.
Results of a NIDA-supported pilot study released on Monday showed that collaboration between physicians and pharmacists could lead to improved medication adherence among patients being treated for opioid use disorder.
Results of a NIDA-supported...
01/12/2021
Addiction Professional
News
01/12/2021
A RAND study published in the Journal of Medical Internet Research finds that telehealth usage soared during the early months of the COVID-19 pandemic, but it was behavioral health diagnoses largely driving the surge, not COVID-related...
A RAND study published in the Journal of Medical Internet Research finds that telehealth usage soared during the early months of the COVID-19 pandemic, but it was behavioral health diagnoses largely driving the surge, not COVID-related...
A RAND study published in the...
01/12/2021
Behavioral Healthcare Executive

Advertisement

Advertisement

Advertisement